Master One Thing - Rapamycin Longevity Series cover image

Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging

Master One Thing - Rapamycin Longevity Series

00:00

Planned Clinical Path: Phase 1 and Challenge Trial

Joan outlines phase 1 plans and a rhinovirus challenge trial to test severity reduction efficiently.

Play episode from 01:06:41
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app